Analysis of the promoter for the herpes simplex virus (HSV) immediate-early (a) gene aO in a short-term transient expression assay revealed that a SacI-to-NcoI fragment from -786 to +148 relative to the cap site directed the synthesis of chloramphenicol acetyltransferase when the fragment was present in either orientation. Although the constitutive levels of promoter activity were similar with either orientation, the reverse-orientation promoter was not induced in response to infection with HSV. Analysis of sequences composing the putative promoter in the opposite orientation revealed the presence of important regulatory elements associated with a promoters. These include an a-trans-inducing factor (a-TIF)-like response element, a high-affinity ICP4-binding site, numerous Spl-binding sites, and a TATA box. Sequences contained within this region formed specific DNA-protein complexes in extracts from mock-infected and HSV-infected HeLa cells. Transient expression assays revealed that this sequence was positively regulated by the a0 and a-TIF genes but negatively regulated by a4. Finally, nuclear run-on transcription assays revealed that this promoter is active in its correct genomic context during the course of virus infection. We suggest that the promoter is a hybrid between an a and 13 promoter because it exhibits maximal expression at 8 h postinfection and is expressed in the presence of cycloheximide.
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Herpes simplex virus type 1 (HSV-1) has a doublestranded DNA genome of approximately 150 kb (31, (45) (46) (47) . The genome contains two stretches of unique sequence DNA differing in size and designated the long unique (UL) and short unique (Us) regions ( Fig. 1) (65, 74) . Flanking the unique sequences are inverted repeats specific to the individual unique regions and designated IRL and IRS. An inverted repeat region common to both unique regions (a) flanks the entire genome and constitutes the joint region between the IRL and IRS regions.
A large number of structural genes and their transcripts have been mapped to this genome (reviewed in reference 75) , and computer-assisted analysis of the virus chromosome sequence has revealed the existence of at least 75 open reading frames (45) (46) (47) . The transcriptional pattern of HSV is temporally regulated and consists of at least three kinetic classes of genes termed immediate early (a), delayed early (1) , and late (-y) (25, 26, 42, 71) . Five a genes encoding the infected-cell proteins (ICPs) 4, 0, 22, 27, and 47 have been described. Transcription of these genes can occur in HSVinfected cells in the absence of protein synthesis (25) . At least three of these gene products, ICPs 4, 0, and 27, are transactivators of subsequent HSV gene expression (13, 17, 44, 52, 57, 59, 62, 64, 77) . Furthermore, ICP4 and ICP27 have been shown to negatively regulate a genes (13, 17, 52, 55, 59, 62, 64, 72) . The 13 genes are expressed prior to the onset of HSV DNA replication but require a-gene expression. These genes can be divided into two subclasses (, 13 and 132) on the basis of their times of expression and abundance.
The y genes are maximally expressed after the onset of viral DNA replication, although they, too, can be divided into two * Corresponding author.
subclasses (-Yl and _Y2) on the basis of obligatory requirement of DNA replication for expression.
A number of regulatory sequence elements are found in ax-gene promoters. One of these, RTCGTCNNYNYSG, is a high-affinity binding site for ICP4 (11, 15, 34) and is thought to be the major negative regulatory element for a promoters (60) . A second sequence element, TAATGARAT, is required for the induction of at genes by the a-trans-inducing factor (a-TIF), an encapsidated y-gene product (16, 39, 40, 54, 79) . Induction by a-TIF occurs through the binding of at least one cellular transcription factor (Octl) to the TAAT GARAT sequence (19, 35, 36, 48, 50, 51, 56) . A third element is the binding site for the cellular transcription factor Spl (28, 29, 73) . It was shown to be required for basal-level expression from the a4 gene promoter (28, 73) .
Circularization of the HSV genome during infection results in the generation of a second joint where the repeats flanking UL and Us are juxtaposed and separated by the a sequences ( Fig. 1) . In the joint, a4 and a0 are transcribed in the same polarity. To date, one gene (y34.5) has been mapped to this region (6, 7) . This gene belongs to the yl subclass and is transcribed in the same polarity as a4 and a0. The only transcription unit thus far identified from the opposite strand is the latency-associated transcription unit (LAT) (8, 9, 20, 61, 67, 69) , which extends from upstream of the polyadenylation site of aoO through the joint to a point near the polyadenylation site of a4 (14) . Although this is the only active transcription unit observed during viral latency, several of the LATs have been observed during productive infection (10, 32, (67) (68) (69) 76) .
Here, we report the identification of a novel promoter mapping within the repeated elements that flank UL. This promoter contains many of the sequence elements found in other HSV promoters, and these elements exhibit the char- (80) .
Plasmid constructs. The null-CAT construct pIGA53 has been described elsewhere (18) Mobility shift and supershift electrophoresis assays. To make the probe for the mobility shift electrophoresis assays, pRAB6 was digested with HindIII (see Fig. 3 ), 3' end labeled in the coding strand by using the Klenow fragment of E. coli DNA polymerase I according to standard protocols (41), excised from upstream sequences by digestion with BglI, subjected to polyacrylamide gel electrophoresis, and, following autoradiography, eluted from the gel matrix as described by Maxam and Gilbert (43) . Unlabeled competitor DNA was prepared in an identical manner and isolated after a preparative polyacrylamide gel was stained with ethidium bromide. The high-affinity ICP4-binding site, simian virus 40 (SV40) "Spl-binding sites" (SV40Ooi), and thymidine kinase (TK) C DNAs have been described elsewhere (53) .
Nuclear extracts from either mock-infected or HSV-1-infected HeLa cells were prepared by the procedure of Dignam et al. (12) as modified by Papavassiliou and Silverstein (53) . Binding reactions and competition analyses were performed essentially as described by the latter (53), and DNA-protein complexes were resolved from free DNA by electrophoresis through native, low-ionic-strength 4% polyacrylamide gels (70) . For "supershift" assays, binding reaction mixtures were further incubated for 40 min with antibody at a concentration of 500 ng/,g of nuclear extract. The antibody reagents used were R22, a polyclonal rabbit antimouse immunoglobulin A Fc control serum (kindly provided by S. Morrison, University of California at Los Angeles); H640, a monoclonal antibody recognizing ICP4 (a generous gift of L. Pereira, University of California at San Francisco);
and HC-1, a monoclonal antibody specific for HSV-1 glycoprotein C (kindly provided by P. G. Spear, Northwestern University).
Nuclear run-on transcription assays. Nuclear run-on transcription assays were performed by a variation of the technique of Weinheimer and McKnight (78) . The differences were that the cells were washed three times in ice-cold phosphate-buffered saline before resuspension in reticulocyte standard buffer containing 0.1% Nonidet P-40 and 20 U Fig. 1 . aO-CAT refers to the fragment cloned in the opposite orientation.
nylpyrrolidone-0.08% Ficoll 400-0.08% bovine serum albumin (fraction V)-2% sodium dodecyl sulfate (SDS)-50% formamide supplemented with 100 ,ug of sonicated denatured calf thymus DNA per ml. The hybridizations were carried out at 47°C for 40 h. The filters were washed twice with 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at 25°C for 15 min, twice with 0.lx SSC-0.5% SDS at 68°C for 30 min, and once in 0.lx SSC at 68°C for 30 min. Following autoradiography, the filters were subjected to two-dimensional 13-emission spectroscopy, and the counts for specific bands were determined.
Nucleotide sequence accession number. The sequence was submitted to the GenBank data base and is available under accession number M34532.
RESULTS
Identification of a functional promoter upstream of the iO promoter. To study regulation-of HSV a-gene transcription, a number of plasmids were constructed in which an indicator gene, the CAT gene, was controlled by one of the four a promoters. In all cases, the fragment containing the promoter was cloned into the CAT gene-containing plasmid in both orientations. Three of the four promoters positively regulated CAT expression in only one orientation and not in reverse orientation (data not shown). The one exception was the fragment containing the aO promoter. This fragment (SacI to NcoI, nucleotides -786 to + 148) expressed CAT in either orientation (Fig. 2) . Vero cells were transfected with 1 to 5 ,ug of plasmid DNA from constructs containing either the CAT gene alone (null-CAT), the CAT gene under the control of the aO promoter (aO-CAT), the CAT gene under the control of the aoO promoter cloned in the reverse orientation (joint-CAT), or the CAT gene under the control of the TK promoter (TK-CAT). At 40 h posttransfection, cells were harvested, protein extracts were prepared, and CAT activity was assayed. As shown in Fig. 2 , the SacI-to-NcoI fragment demonstrated comparable levels of activity in either orientation, although the aO promoter orientation gave slightly higher levels of CAT activity. Either orientation gave higher levels of activity than the TK-CAT construct, and activity from the null-CAT construct was negligible. To test whether the novel promoter was induced by virus infection, cells transfected with 5 ,ug of each of the preceding constructs were either mock-infected or infected with HSV-1(F) at various multiplicities of infection (MOIs) at 40 h posttransfection. At 2, 6, or 10 h postinfection, cells were harvested, protein extracts were prepared, and CAT activity was assayed (Table 1) . Very little CAT activity was detected, either with or without HSV infection, in extracts from cells transfected with the promoterless plasmid. The aO-CAT chimera exhibited a basal level of expression approximately 400-fold higher than that of the null-CAT. This expression was further induced 8-to 10-fold in response to infection with HSV-1(F). CAT activity from the reverseorientation CAT chimera was approximately one-half that of the OtO-CAT chimera but was not induced more than two-to threefold by HSV-1 infection at any MOI tested. As a control, the f3 TK-CAT chimera was also tested, and it exhibited induction as high as sixfold within the time frame tested, although only at a low MOI. The levels of TK-CAT activity were approximately two-to fivefold less than the basal levels of either the joint-CAT or the cO-CAT constructs. Cells transfected with joint-CAT and harvested at 16 h postinfection also were not induced (data not shown). These experiments were repeated in HeLa cells, and although the levels of activity were not as high as those seen with Vero cells, the same patterns of induction were observed (data not shown).
The promoter fragment used in these studies was derived from HSV-1(KOS). This region of KOS had not been previously sequenced. Therefore, we cloned the promoter region from the joint-CAT construct as three separate fragments in M13 phages mpl8 and mpl9 as described in Materials and Methods. The complete sequence from the SphI site to the HindIII linker site at the HSV-1-CAT junction was aligned with the corresponding sequences from HSV-1(F) (6, 7) and HSV-1(17syn+) (45) and compared. All three sequences were scanned for known transcription factor-binding sites. The results of this analysis are seen in Fig. 3 . A high-affinity ICP4-binding site, required for the down regulation of a genes, was found 41 Functional analysis of binding sites within the promoter.
The presence of four regulatory elements within this region suggested a role for the binding of one or more of the factors which recognize these elements in transcriptional regulation. Mobility shift electrophoresis assays were performed to examine the abilities of some of these sequences to form DNA-protein complexes in extracts from uninfected and infected cells. A DNA probe extending from the HindIII site at the junction between the CAT gene and the HSV-1 sequences to a BglI site 82 bp upstream (Fig. 3) was analyzed. This fragment contains sequences known to bind ICP4, the TFIID box, and the adjacent Spl-binding site. The fragment was end labeled, isolated from polyacrylamide gels, and incubated with crude nuclear extracts prepared from either mock-infected or HSV-1-infected HeLa cells. The reaction mixtures were then analyzed for the presence of discrete DNA-protein complexes by the mobility shift electrophoresis assay.
A mobility shift analysis of the probe is presented in Fig.  4A . When the binding reactions were performed with extracts from mock-infected cells in the presence of 5 mM NaCl, four complexes were detected. Three of these were stable at an elevated ionic strength (50 mM NaCl), with a higher yield of the slower-migrating species. The specificity of these interactions was demonstrated by competition assays in which the labeled probe was incubated in the presence of excess homologous or heterologous DNA. The concentration of unlabeled competitor fragments was approximated from the intensity of their fluorescence in ethid- ium bromide-stained gels relative to that of known concentrations of marker fragments. The homologous fragment inhibited complex formation with the labeled DNA (Fig. 4B) . Similarly, a 49-bp fragment containing a high-affinity ICP4 binding site derived from the ca4 promoter (nucleotides -17 to +32 relative to the mRNA cap site) competed efficiently. Less competition was observed with a fragment from the SV40 promoter, which contained multiple copies of the Spl-binding site. No effect on complex formation was seen with a heterologous fragment from the TK gene (TK C; nucleotides +53 to +140 relative to the mRNA cap site), which contains neither an ICP4-binding site nor an Splbinding site.
A single species, which was more abundant under the low-salt conditions, was formed with extracts from HSV-1-infected cells (Fig. 4A) . Analogous competition assays performed using these extracts demonstrated that complex formation was inhibited by homologous DNA or by DNA containing the high-affinity ICP4-binding site from the a4 promoter (Fig. 4C) . The amount of radioactivity in each band was quantitated by two-dimensional 3-emission spectroscopy and is graphically portrayed in Fig. 5 . The degree of competition was virtually identical whether the competitor was the probe itself or a fragment from the a4 gene containing another high-affinity ICP4-binding site. No competition was detected with either the SV40 promoter fragment containing the Spl-binding sites or the fragment containing the TK sequences. Chemical nuclease cleavage analysis of the bound fragment using extracts from infected cells confirmed that the region of the probe protected by protein corresponded to the high-affinity ICP4-binding site (data not shown). A region from +1 to +13 (relative to the initial purine residue in the binding site) was protected from cleavage. These results are indistinguishable from those described by DiDonato et al. (11) , who used partially purified ICP4 to study this interaction.
The protection of a region on the probe containing sequences known to bind ICP4 in infected-cell extracts suggested the participation of ICP4 in complex formation. This was verified by utilizing the ability of a monoclonal antibody specific for ICP4 to be tethered to the protein and further reduce the electrophoretic mobility of the complex obtained in infected-cell extracts (33) . The results of this analysis are seen in Fig. 6A . In mock-infected cell extracts, three stable complexes were seen when the extracts were incubated with normal rabbit serum (R22). No change in mobility was detected after these complexes were incubated with H640, a monoclonal antibody that recognizes ICP4, or with HC-1, a control monoclonal antibody specific for HSV-1 glycoprotein C. In contrast, incubation of these antibodies with complexes formed by using extracts prepared at 2.5, 5, and 10.5 h postinfection revealed the presence of a slowlymigrating species that was not detected with either polyclonal normal rabbit serum or antibody specific for glycoprotein C. The amounts of radioactivity in the control bands (R22) and the supershifted bands (H640) were determined by two-dimensional 13-emission spectroscopy (Fig. 6B) effector plasmids at various ratios of effector to target. At 40 h posttransfection, cells were harvested, protein extracts were made, and CAT activity was measured. The results of this assay are shown in Fig. 7 .
The effect of the ICP4-expressing construct on the aO promoter is similar to what has been previously reported for other a promoters (18) . At low molar ratios of effector to target, ICP4 induces the aO promoter approximately two-to threefold, but at higher ratios, the promoter is repressed to a point below the basal level of expression. In contrast, the novel promoter is always repressed even at low ratios of effector to target.
The response of the novel promoter to low levels of either ICPO or a-TIF is similar to that seen with the aO promoter except that the levels of expression from the novel promoter are lower. The overall pattern of response as determined by fold induction is the same. Both promoters are induced approximately 7-fold by ICP0 at low ratios and 10-to 20-fold by ao-TIF at low ratios. When induction with a-TIF is done at high ratios of effector to target, a second peak of activity is seen with the aO but not with the novel promoter.
Expression of the novel promoter during virus replication. To ask whether this promoter sequence is active during virus infection, nuclear run-on assays were employed. A fragment was cloned into M13 phage vectors for the purpose of making strand-specific probes which would detect transcription downstream of the putative promoter. The fragment extended from the SacI site 54 bp downstream of the TATA box to a BstEII site located 697 bp further downstream. This fragment was cloned into mpl8 and mpl9, and the constructs were called (RAB1 and 4RAB2, respectively (Fig. 8C) . 4RAB1 detects nascent transcription with the same polarity as the promoter, and 4RAB2 detects antisense transcription, which should correspond to expression from the Yi34-5 gene. Because the putative promoter was located within one of the LATs (14) , transcription from a region upstream of this sequence was analyzed to demonstrate differences in rates. A 1.6-kbp SacI-to-BamHI fragment containing the aoO promoter and part of its transcription unit was cloned in both orientations in M13 vectors (Fig. 8C) . These single-stranded DNAs were used as probes to detect nascent transcripts from the aO promoter (a0-11) and the LAT promoter (a0-18).
Vero cells were infected with HSV-1(17syn+) at an MOI of 20, incubated, and harvested at various times postinfection. Nuclei were prepared and incubated in a buffer containing [aL-32P]GTP under conditions which allowed transcriptional elongation. After incubation, the labeled RNAs were extracted from the nuclei and hybridized to filters containing the specific probes. The results are shown in Fig. 8A and quantitated in Fig. 8B .
Although no transcription was detected with vector-only probes, a low level of transcription downstream of the promoter region was detected by 4RAB1 at 6 h postinfection; this level reached its maximum later in infection (Fig.   8) . In contrast, a low level of transcription of LAT was detected by the aO-18 probe at 4 h postinfection. Transcription increased until 8 h postinfection and declined at the next time point. Therefore, the kinetics of synthesis of these transcripts are markedly different.
Although the time course of transcription suggested that the promoter behaved as a 2 or yl promoter, the presence within the promoter of two sequence elements which regulate a transcription, the Octl-x-TIF response element and a high-affinity ICP4-binding site (Fig. 3) , and the response of the promoter to ICP4 and a-TIF in transient expression assays (Fig. 7) suggested that the promoter may also have characteristics common to a promoters. To test this possibility, nuclear run-on assays were used to measure transcription in cells infected with HSV-1 in the presence of cycloheximide. Cells were treated with 100 p,g of cycloheximide per ml at 15 min prior to infection and maintained in cycloheximide throughout the 6-h course of infection. A subset of treated cells was washed free of cycloheximide at 5 h postinfection and allowed to incubate in cycloheximidefree medium for 1 h prior to harvest. The results of this experiment are also shown in Fig. 9A and B.
The aO-11 probe identified a transcription unit with an a-gene expression pattern. The level of transcription was threefold greater in cycloheximide-treated cells than in untreated cells, and reversal of cycloheximide resulted in a sixfold decrease in otO transcription. The downstream probe of the novel promoter, ORAB1, also detected transcription levels which increased in cycloheximide-treated cells and then decreased after reversal of the drug treatment. In this case, however, the induction was approximately eightfold, leading to an absolute level of transcription almost as high as that of a0. Furthermore, drug reversal completely abolished transcription detected by (RAB1. In contrast to a0-11 and 4RAB1, aO-18 and RAB23 (a smaller probe circumscribed by a0-18 which does not overlap the aoO transcription unit) demonstrated a decreased level of transcriptional activity with cycloheximide treatment which remained low after drug reversal.
DISCUSSION
Identification of a novel promoter. We have described the existence in the HSV-1 genome of a promoter located upstream of and in opposite orientation to the aO promoter.
The location of the promoter relative to the aoO cap site (-786 to + 148) and its orientation (opposite to aO) places it within the LAT region of the genome. The identification of this --s- This is consistent with the presence of the ICP4-binding site and the negative response to ICP4 and is characteristic of a promoters. These results suggest that several factors are involved in regulation of this promoter. First, in the absence of viral factors, cellular factors mediate a relatively high level of expression. Spl is potentially involved in this process. After the onset of viral gene expression, an ao gene product, possibly ICP4, acts as a negative regulatory element. The delayed early phenotype of the promoter in the presence of ICP4 may reflect the requirement of another unknown gene product, either ao or 13, acting as a positive regulator to induce gene expression in the presence of negative regulation. One possible candidate for this effector is ICPO. It is also possible that oa-TIF plays some role in the activity of this promoter.
The identification of this promoter suggests the existence of an as-yet-undescribed transcription unit in this region of the HSV-1 genome. In fact, two cytoplasmic polyadenylated transcripts of 0.9 and 4.0 kb are detected in Northern (RNA) blots when, as a probe, the same downstream fragment used in the nuclear run-on transcription assays is used (2a). We have not been able to map the 5' ends of these transcripts, but the transcripts are also seen in cells infected with a mutant of HSV-1 lacking the LAT promoter and are therefore not processed forms of LAT. However, the mature RNAs are not detected in the presence of cycloheximide. This suggests that yet another a gene product is required for RNA maturation and/or transport of RNA to the cytoplasm. Recently, ICP27 was shown to function in this way on certain herpesvirus gene transcripts, and it is a likely candidate for this process (66) .
We have demonstrated the presence of a novel promoter within the HSV-1 genome and suggested the existence of a novel transcription unit. The promoter defies classification regarding its kinetic group, although overall, the gene may be a member of the 13 class. Clearly, this novel transcription unit is poorly understood and requires further study before its regulation and function can be understood.
